Nektar Therapeutics reports results for the quarter ended in June - Earnings Summary

Nektar Therapeutics

09/08/2024 02:34

* Nektar Therapeutics  NKTR.OQ  reported a quarterly
adjusted loss
of 25 cents​​ per share for the quarter ended in June, higher
than the same quarter last year, when the company reported EPS
of -27 cents.  The mean expectation of five analysts for the
quarter was for a loss of 20 cents per share. Wall Street
expected results to range from -24 cents to -17 cents per share.
    * Revenue rose 14.6% to $23.49 million from a year ago;
analysts
expected $17.55 million. 
    * Nektar Therapeutics's reported EPS for the quarter was a
loss
of 25 cents​.
    * The company reported a quarterly loss of $52.36 million.
    * Nektar Therapeutics shares had fallen by 4.8% this
quarter and
gained 108.8% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 1.8%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "hold"

Wall Street's median 12-month price target for Nektar
Therapeutics is $1.60 
This summary was machine generated from LSEG data August 9 at
01:34 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.20          -0.25          Missed
 Mar. 31 2024      -0.19          -0.19          Met
 Dec. 31 2023      -0.21          -0.22          Missed
 Sep. 30 2023      -0.20          -0.24          Missed